Results 11 to 20 of about 255,287 (218)

ERA OF CONJUGATE VACCINES: INTERNATIONAL EXPERIENCE OF SUCCESSFUL APPLICATION

Педиатрическая фармакология, 2008
The article highlights comparative characteristics of the polysaccharide and conjugate vaccines against pneumococcal infection, meningococcosis and haemophilus influenza. The author stresses the advantage of the conjugate vaccines.
M.V. Fedoseenko, M.G. Galitskaya, L.S. Namazova   +2 more
doaj   +4 more sources

Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia

Emerging Infectious Diseases, 2005
A study of children was conducted in 3 Central Asian Republics. Approximately half of the Streptococcus pneumoniae isolates were serotypes included in available vaccine formulations. Approximately 6% of children carried Haemophilus influenzae type b (Hib)
Stephanie H. Factor, Leslye LaClaire, Melinda Bronsdon, Fleura Suleymanova, Gulbanu Altynbaeva, Bakhtiyar A. Kadirov, Uulkan Shamieva, Scott F. Dowell, Anne Schuchat, Richard Facklam, Benjamin Schwartz, Terence Chorba   +11 more
doaj   +2 more sources

Evaluation of Haemophilus influenzae Type B Conjugate Vaccine (Meningococcal Protein Conjugate) in Canadian Infants [PDF]

Canadian Journal of Infectious Diseases, 1994
Objective: To assess adverse effects and immune responses with a three-dose series of Haemophilus influenzae type b meningococcal protein conjugate (PedvaxHIB or Hib.OMP) vaccine, including any immunological response alterations from concurrent ...
David W Scheifele, Gordean L Bjornson, William G Meekison, Roland Guasparini, Leslie A Mitchell   +4 more
doaj   +2 more sources

Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death

Vaccines, 2020
Various studies indicate that vaccination, especially with pneumococcal vaccines, protects against symptomatic cases of SARS-CoV-2 infection and death.
Robert Root-Bernstein
doaj   +2 more sources

Vaccination for the control of childhood bacterial pneumonia - Haemophilus influenzae type b and pneumococcal vaccines

Pneumonia, 2013
Pneumonia in childhood is endemic in large parts of the world and in particular, in developing countries, as well as in many indigenous communities within developed nations.
Diana C Otczyk, Allan W Cripps
doaj   +2 more sources

Past and Present Vaccinations in Sweden. [PDF]

Acta Paediatr
Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Silfverdal SA.
europepmc   +2 more sources

Changes in Post-Transplant Vaccine Coverage After Implementing Structured Vaccine Reviews in Pediatric Solid Organ Transplant Recipients in British Columbia, Canada: A Canadian Immunization Research Network Study. [PDF]

Pediatr Transplant
Structured annual infectious diseases specialist‐led vaccine reviews, including individualized recommendations, standardized checklists, and facilitated vaccine access, integrated into routine post‐transplant care, significantly improved vaccine coverage in pediatric solid organ transplant recipients.
Barbey FA, Sadarangani M, Burton C, Urschel S, MacDonald SE, McConnell A, Morin E, Meesters K, Blydt-Hansen T, Yong E, Mitchell H, Special Immunization Clinic Network Investigators.   +11 more
europepmc   +2 more sources

Haemophilus influenzae type b disease in the era of conjugate vaccines: Critical factors for successful eradication [PDF]

, 2020
INTRODUCTION: Prior to implementation of Haemophilus influenzae type b (Hib)-conjugate vaccination programs in the 1990s, Hib was the commonest cause of bacterial meningitis in children aged 29,000 deaths worldwide in children aged
Nissen, Michael, Mukherjee, Piyali, Slack, Mary, Haas, Hervé, Mihalyi, Attila, Harrington, Lauriane, Esposito, Susanna   +6 more
core   +3 more sources

Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials. [PDF]

, 2012
Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased considerably during the past decade, partly due to GAVI Alliance donations of the vaccine to low-income countries. In settings where large numbers of children receive
Clark, A, Mulholland, KE, Griffiths, UK, Miners, A, Gessner, B, Sanderson, C, Sedyaningsih, ER   +6 more
core   +1 more source

A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate [PDF]

, 2016
Three important physical properties which may affect the performance of glycoconjugate vaccines against serious disease are molar mass (molecular weight), heterogeneity (polydispersity), and conformational flexibility in solution.
Harding, Stephen E., Conrath, K., Almuntari, F., Almutairi, Fahad M., Duvivier, Pierre, Harding, S. E., Adams, G. G., Morris, Gordon, Duvivier, P., Morris, Gordon A., Abdelhameed, Ali Saber, Adams, Gary G., Abdelhameed, A. S., Conrath, Karel, GSK Vaccines, Rue de l’Institut 89, B-1330 Rixensart, Belgium, Morris, Gordon A.; id_orcid   +15 more
core   +1 more source